The core competencies at Healthcare Economics include but are not limited to expert analysis of intellectual property, technology evaluations as well as forming strategic alliances to enable firms to reach their maximum potential.
IP and Technology Evaluation
HCE has proven experience in technology assessment, valuation and determining pricing for intellectual property. It is imperative that the licensor and licensee come to a meeting of the minds and are mutually satisfied in their quest to close a deal.
Business scenarios such as early and late stage projects are uniquely different and have specific circumstances requiring an individualized approach in order that both parties are satisfied with their positions and receive equitable value for said projects. HCE will work to ensure that all parties are mutually satisfied within their respective positions.
Typically during due diligence many factors are considered culminating in the development of business strategies such as the net present value (NPV), internal rate of return (IRR), and cash flow analysis (CFA) models developed and shared between the licensor and licensee in order to establish and agree upon the value of the given opportunity.
Strategic Alliances
Many firms are actively seeking partners to develop a strategic alliance whereby each firm agrees on a specific set of objectives and goals to form collaborations. This synergy is particularly important due to the fact that each partner seeks to benefit from the strength of the alliance.
HCE is ideally suited to help firms achieve strategic alliances. Our consultants are experienced with technical backgrounds in international marketing, licensing, finance, and business development and have strong business ties in North and South America, Europe, Asia and the MENA region to assist firms seeking alliances.
In-Out Licensing
Many firms will find it compelling and advantageous to in-license or out-license products within various stages of development. Academia may want to partner its early stage products with a firm well experienced within product development and commercialization. HCE will assist in bringing these two potential partners together to forge a mutually rewarding relationship.
Many firms facing a patent cliff whereby this challenge becomes an opportunity and HCE will provide assistance to those companies looking to place products with firms actively seeking to supplement their pipelines for future growth.
Merger and Acquisition Support
HCE will drive value throughout the deal lifecycle providing strategic merger and acquisition (M&A) and divesture support starting from due diligence, through valuation and culminating in deal closure.
Successful deals are a combination of supply and demand, experience, negotiating skills, financial analysis and the willingness to see it through. Our experienced multicultural international team has experience in this area and offers the added benefit of a comprehensive understanding of local cultures and business practices that enhance the desired outcome.
Sales and Marketing Business Modeling
HCE has experience in developing commercial teams within sales, marketing, market access and reimbursement to assist firms to reach critical mass within their industries.
HCE will support firms interested in maximizing sales and marketing efforts to penetrate specific business segments. Directed commercialization efforts are crucial in terms of product success and HCE is experienced in analyzing new and existing business trends, creating business models, and implementing strategies to capture market share.
Direct to Consumer Sales and Marketing
It is a given fact that more households are wired to the internet and individuals are introduced to an onslaught of information for various venues. The internet is a tool that allows individuals to become educated and empowered on a continuous basis. Given this reality the case can be made for the direct to consumer (DTC) channel as a necessary tool for many cutting edge firms to employ in order to convey clear and concise marketing messages in regard to disease management, products, patient compliance and outcomes.
HCE has experienced consultants to assist firms to capture this opportunity by extending brand awareness through the medium of DTC digital awareness and empowering patients to become active participants within their treatment plans with their providers and payers. Due to this new paradigm patients are becoming empowered through the use of digital media and firms must step up or run the risk of loosing valuable market share to other firms seeking to capitalize upon said business model.
Market Access and Reimbursement
Skill sets needed to achieve sales and marketing objectives are changing. In the old business model, firms employed individuals to call on various departments within the hospitals and clinics to drive sales. Market access and reimbursement has become an area of increasing importance due to the fact that policy changes have been enacted in the states such as the Patient Protection and Affordable Care Act (PPACA) and internationally where government payers exude enormous influence to maximize healthcare resources to deliver a meaningful quantifiable return on investment.
Payers have become increasingly important and pharmacoeconomics has now become a key area of discussion and mutual benefit. Key decision makers are not only interested in how the drug works but whether the therapy can deliver a meaningful benefit while lowering overall healthcare costs. HCE has experienced consultants to assist firms interested in delivering value to all stakeholders including payers, providers, and patients in this new paradigm.
|